Silk nanoparticles - an emerging anticancer nanomedicine

Research output: Contribution to journalArticle

Abstract

Silk is a sustainable and ecologically friendly biopolymer with a robust clinical track record in humans for load bearing applications, in part due to its excellent mechanical properties and biocompatibility. Our ability to take bottom-up and top-down approaches for the generation of silk (inspired) biopolymers has been critical in supporting the evolution of silk materials and formats, including silk nanoparticles for drug delivery. Silk nanoparticles are emerging as interesting
contenders for drug delivery and are well placed to advance the nanomedicine field. This review covers the use of Bombyx mori and recombinant silks as an anticancer nanomedicine, highlighting the emerging trends and developments as well as critically assessing the current opportunities and challenges by providing a context specific assessment of this multidisciplinary field.
LanguageEnglish
Pages239-258
Number of pages20
JournalAIMS Bioengineering
Volume42
Issue number2
DOIs
Publication statusPublished - 22 Mar 2017

Fingerprint

Nanomedicine
Medical nanotechnology
Silk
Nanoparticles
Biopolymers
Drug delivery
Bearings (structural)
Bombyx
Weight-Bearing
Biocompatibility
Pharmaceutical Preparations
Mechanical properties

Keywords

  • silk
  • fibroin
  • nanomedicine
  • nanoparticle
  • drug delivery
  • Bombyx mori
  • targeting
  • EPR
  • endocytosis

Cite this

@article{1fce3bb6191c433587816f5225bb5eaa,
title = "Silk nanoparticles - an emerging anticancer nanomedicine",
abstract = "Silk is a sustainable and ecologically friendly biopolymer with a robust clinical track record in humans for load bearing applications, in part due to its excellent mechanical properties and biocompatibility. Our ability to take bottom-up and top-down approaches for the generation of silk (inspired) biopolymers has been critical in supporting the evolution of silk materials and formats, including silk nanoparticles for drug delivery. Silk nanoparticles are emerging as interestingcontenders for drug delivery and are well placed to advance the nanomedicine field. This review covers the use of Bombyx mori and recombinant silks as an anticancer nanomedicine, highlighting the emerging trends and developments as well as critically assessing the current opportunities and challenges by providing a context specific assessment of this multidisciplinary field.",
keywords = "silk, fibroin, nanomedicine, nanoparticle, drug delivery, Bombyx mori, targeting, EPR, endocytosis",
author = "Seib, {F. Philipp}",
year = "2017",
month = "3",
day = "22",
doi = "10.3934/bioeng.2017.2.239",
language = "English",
volume = "42",
pages = "239--258",
journal = "AIMS Bioengineering",
issn = "2375-1495",
number = "2",

}

Silk nanoparticles - an emerging anticancer nanomedicine. / Seib, F. Philipp.

In: AIMS Bioengineering, Vol. 42, No. 2, 22.03.2017, p. 239-258.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Silk nanoparticles - an emerging anticancer nanomedicine

AU - Seib, F. Philipp

PY - 2017/3/22

Y1 - 2017/3/22

N2 - Silk is a sustainable and ecologically friendly biopolymer with a robust clinical track record in humans for load bearing applications, in part due to its excellent mechanical properties and biocompatibility. Our ability to take bottom-up and top-down approaches for the generation of silk (inspired) biopolymers has been critical in supporting the evolution of silk materials and formats, including silk nanoparticles for drug delivery. Silk nanoparticles are emerging as interestingcontenders for drug delivery and are well placed to advance the nanomedicine field. This review covers the use of Bombyx mori and recombinant silks as an anticancer nanomedicine, highlighting the emerging trends and developments as well as critically assessing the current opportunities and challenges by providing a context specific assessment of this multidisciplinary field.

AB - Silk is a sustainable and ecologically friendly biopolymer with a robust clinical track record in humans for load bearing applications, in part due to its excellent mechanical properties and biocompatibility. Our ability to take bottom-up and top-down approaches for the generation of silk (inspired) biopolymers has been critical in supporting the evolution of silk materials and formats, including silk nanoparticles for drug delivery. Silk nanoparticles are emerging as interestingcontenders for drug delivery and are well placed to advance the nanomedicine field. This review covers the use of Bombyx mori and recombinant silks as an anticancer nanomedicine, highlighting the emerging trends and developments as well as critically assessing the current opportunities and challenges by providing a context specific assessment of this multidisciplinary field.

KW - silk

KW - fibroin

KW - nanomedicine

KW - nanoparticle

KW - drug delivery

KW - Bombyx mori

KW - targeting

KW - EPR

KW - endocytosis

UR - http://www.aimspress.com/journal/Bioengineering

U2 - 10.3934/bioeng.2017.2.239

DO - 10.3934/bioeng.2017.2.239

M3 - Article

VL - 42

SP - 239

EP - 258

JO - AIMS Bioengineering

T2 - AIMS Bioengineering

JF - AIMS Bioengineering

SN - 2375-1495

IS - 2

ER -